191 related articles for article (PubMed ID: 25224382)
1. Long-lasting uveitis remission and hearing loss recovery after rituximab in Vogt-Koyanagi-Harada disease.
Caso F; Rigante D; Vitale A; Costa L; Bascherini V; Latronico E; Franceschini R; Cantarini L
Clin Rheumatol; 2015 Oct; 34(10):1817-20. PubMed ID: 25224382
[TBL] [Abstract][Full Text] [Related]
2. Bilateral dexamethasone intravitreal implant in a young patient with Vogt-Koyanagi-Harada disease and refractory uveitis.
Latronico ME; Rigante D; Caso F; Cantarini L; Costa L; Nieves-Martín L; Traversi C; Franceschini R
Clin Rheumatol; 2015 Jun; 34(6):1145-8. PubMed ID: 24763751
[TBL] [Abstract][Full Text] [Related]
3. [Sensorineural hearing loss evolution in Vogt-Koyanagi-Harada syndrome].
Rodríguez Rivera V; Garrigues HP; Gallego Pinazo R
Acta Otorrinolaringol Esp; 2011; 62(6):465-8. PubMed ID: 21167466
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of B Cell Depletion Therapy with Rituximab in Refractory Chronic Recurrent Uveitis Associated with Vogt-Koyanagi-Harada Disease.
Abu El-Asrar AM; Dheyab A; Khatib D; Struyf S; Van Damme J; Opdenakker G
Ocul Immunol Inflamm; 2022 Apr; 30(3):750-757. PubMed ID: 32990482
[TBL] [Abstract][Full Text] [Related]
5. Rituximab for sight-threatening refractory pediatric Vogt-Koyanagi-Harada disease.
Umran RMR; Shukur ZYH
Mod Rheumatol; 2018 Jan; 28(1):197-199. PubMed ID: 26154298
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of intravitreal dexamethasone implant in patients with Vogt-Koyanagi-Harada Disease and bilateral panuveitis: Two case reports.
Chen PL; Chen SN
Medicine (Baltimore); 2021 Oct; 100(40):e27394. PubMed ID: 34622843
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporin therapy in Vogt Koyanagi Harada disease.
Wakefield D; McCluskey P; Reece G
Aust N Z J Ophthalmol; 1990 May; 18(2):137-42. PubMed ID: 2390240
[TBL] [Abstract][Full Text] [Related]
8. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Hemachandran S; Al-Mezaine HS; Kangave D; Al-Muammar AM
Acta Ophthalmol; 2012 Dec; 90(8):e603-8. PubMed ID: 22971163
[TBL] [Abstract][Full Text] [Related]
9. Systemic corticosteroid treatment in Vogt-Koyanagi-Harada disease.
Hayasaka S; Okabe H; Takahashi J
Graefes Arch Clin Exp Ophthalmol; 1982; 218(1):9-13. PubMed ID: 7056483
[TBL] [Abstract][Full Text] [Related]
10. [Vogt-Koyanagi-Harada syndrome. Eight cases].
Alaoui FZ; Benamour S; El Kabli H; Amraoui A
Rev Med Interne; 2007 Apr; 28(4):250-4. PubMed ID: 17350144
[TBL] [Abstract][Full Text] [Related]
11. [Long-term course of immunosuppressive therapy of Vogt-Koyanagi-Harada syndrome].
Wand K; Abraham S; Loos D; Stumpfe S; Lohmann C; Maier M; Feucht N
Ophthalmologe; 2015 Oct; 112(10):857-60. PubMed ID: 25680347
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A
Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
[TBL] [Abstract][Full Text] [Related]
13. An unusual cause of vertigo, tinnitus, and hyperacusis: Vogt-Koyanagi-Harada syndrome.
Gaudreau P; Moy J; Lindsay F
Ear Nose Throat J; 2012 Dec; 91(12):E7-9. PubMed ID: 23288830
[TBL] [Abstract][Full Text] [Related]
14. Bilateral Cochlear Implantation in Vogt-Koyanagi-Harada Syndrome: A Case Report.
AlHelali N; Hajr E; Almuhawas F; Hagr A
Otol Neurotol; 2019 Aug; 40(7):e694-e697. PubMed ID: 31219962
[TBL] [Abstract][Full Text] [Related]
15. Studies on corticosteroid therapy in Vogt-Koyanagi-Harada disease.
Sasamoto Y; Ohno S; Matsuda H
Ophthalmologica; 1990; 201(3):162-7. PubMed ID: 2089358
[TBL] [Abstract][Full Text] [Related]
16. Reversal of Peripheral Iris Depigmentation Associated with Vogt-Koyanagi-Harada Disease.
Tobaigy MF; AlBloushi AF; Al-Dhibi HA
Ocul Immunol Inflamm; 2024 May; 32(4):424-428. PubMed ID: 36657743
[TBL] [Abstract][Full Text] [Related]
17. [Repeated pulse corticosteroid therapy in Vogt-Koyanagi-Harada disease. A case report].
Denoyer A; Le Lez ML; Arsène S; Pisella PJ
J Fr Ophtalmol; 2004 Apr; 27(4):404-8. PubMed ID: 15173651
[TBL] [Abstract][Full Text] [Related]
18. [Vogt Koyanagi Harada syndrome. Report of a case with hearing loss, tinnitus, vertigo associated to uveitis].
Pino Rivero V; Pardo Romero G; Rodríguez Carmona M; Iglesias González RJ; del Castillo Beneyto F
An Otorrinolaringol Ibero Am; 2007; 34(3):281-5. PubMed ID: 17725172
[TBL] [Abstract][Full Text] [Related]
19. A case presentation of an IgA nephropathy patient with Vogt-Koyanagi-Harada syndrome.
Zhang Q; Fan X; Tian M; Han H
BMC Nephrol; 2020 Jul; 21(1):272. PubMed ID: 32660433
[TBL] [Abstract][Full Text] [Related]
20. Triple agent immunosuppressive therapy in Vogt-Koyanagi-Harada syndrome.
Agarwal M; Ganesh SK; Biswas J
Ocul Immunol Inflamm; 2006 Dec; 14(6):333-9. PubMed ID: 17162603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
